UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 20, 2023 4:15 P.M.
Form:
S-4
CIK:
0001621227
Company Name:
Adaptimmune Therapeutics PLC
File Number:
333-271145